Company intelligence / Profile preview
Triastek
Nanjing, Jiangsu, Chinatriastek.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Phase 2
01
Overview
Triastek has established itself as a global leader in the application of proprietary pharmaceutical-grade additive manufacturing. Its lead programs leverage the MED® platform for precise control over drug release profiles and targeted delivery. The company has completed more than ten human data validations and received FDA IND clearance for its gastric retention product T20G. Its T21 program for ulcerative colitis has successfully completed first-in-human trials.
- Therapeutic areas
- OtherRheumatologyGastroenterologyCardiovascularNephrology
- Modalities
- Small molecules (oral solid dosage forms)Oral biologics/peptidesRNA therapeutics (in collaboration with BioNTech)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Eli LillyMerck KGaABoehringer IngelheimSiemensSperogenixBioNTech SE [for oral RNA therapeutics].
Beyond the preview
Go deeper on Triastek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Triastek.